Showing results (831-840 of 1,690) with videos related to
Sort By:
Pageof 169
Transfusion Medicine (Oxford, England)|June 11, 2021
Role of ABO blood system in COVID-19: Findings from a southern Italian studyPierpaolo Negro, Maurizio Congedo, Antonella Zizza, et al.Transfusion Medicine (Oxford, England)|December 17, 2020
Convalescent plasma therapy for the treatment of patients with COVID-19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levelsHeli Harvala, Matthew L Robb, Nick Watkins, et al.Transfusion Medicine (Oxford, England)|October 5, 2020
Inter-donor variability in deformability of red blood cells in blood unitsGregory Barshtein, Tanja L Rasmusen, Orly Zelig, et al.Transfusion Medicine (Oxford, England)|June 6, 2022
Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approachJessie S Luken, Sebastien P Ritsema, Merel M Van der Wal, et al.Transfusion Medicine (Oxford, England)|June 24, 2022
Demographic, clinical, and biochemical predictors of pica in high-intensity blood donorsHefei Liu, Robert T Burns, Bryan R Spencer, et al.Transfusion Medicine (Oxford, England)|June 25, 2022
Blood donor notification of variant Creutzfeldt-Jakob disease risk: Lessons in communicating donor deferral and riskClaire A Reynolds, Tali Yawitch, Patricia E Hewitt, et al.Transfusion Medicine (Oxford, England)|June 25, 2022
Using a scenario approach to assess for the current and future demand of immunoglobulins: An interview and literature study from The NetherlandsPraiseldy Langi Sasongko, Marian van Kraaij, Cynthia So-OsmanTransfusion Medicine (Oxford, England)|October 1, 2010
Prevalence and genetic heterogeneity of SEN virus genotypes D and H in blood donors from Central and Western Europe and West AfricaK Thom, A Cleland, M Salakova, et al.Transfusion Medicine (Oxford, England)|January 5, 2011
Procoagulant activity of long-term stored red blood cells due to phosphatidylserine exposureC Lu, J Shi, H Yu, et al.Transfusion Medicine (Oxford, England)|January 7, 2011
Establishment of a cell line panel as an alternative source of platelet antigens for a screening assay of anti-human platelet antibodiesT Hayashi, E Amakishi, N Matsuyama, et al.Pageof 169